Actuate Therapeutics, Inc. – Underwriting Agreements

NASDAQ: ACTU
Share price (11/6/26): $0.33
Market cap (11/6/26): $18.1 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

from SCHEDULE 13G 1 page Exhibit 1 Joint Filing Agreement Pursuant to Rule 13d-1

from 8-K 55 pages Underwriting Agreement Between Actuate Therapeutics, Inc. and Newbridge Securities Corporation Actuate Therapeutics, Inc. Underwriting Agreement

from S-1/A 65 pages Underwriting Agreement Between Actuate Therapeutics, Inc. and Newbridge Securities Corporation 1 Actuate Therapeutics, Inc. Underwriting Agreement

from S-1 53 pages Underwriting Agreement Between Actuate Therapeutics, Inc. and Konik Capital Partners, LLC, a Division of T.R. Winston & Company, LLC as Representative of the Several Underwriters Actuate Therapeutics, Inc. Underwriting Agreement

from 8-K 40 pages Actuate Therapeutics, Inc. Common Stock (Par Value $0.000001 Per Share) at Market Issuance Sales Agreement

from 8-K 31 pages 2,142,858 Shares of Common Stock Actuate Therapeutics, Inc. Underwriting Agreement

from SC 13D 13 pages Lock-Up Agreement

from S-1/A 44 pages [ ] Shares of Common Stock Actuate Therapeutics, Inc. Underwriting Agreement

from S-1/A 44 pages [ ] Shares of Common Stock Actuate Therapeutics, Inc. Underwriting Agreement